Mark Elliott Boulding, EXEC. VP AND CLO at PTC Therapeutics, holds 106.85K shares in PTC Therapeutics (Ticker: PTCT). Most recently, Mark Elliott Boulding Sold $3,541 shares of PTC Therapeutics on Jan 10, 2025 for an estimated value of 158.87K.
What is the percentage of profitable transactions made by Mark Elliott Boulding?
The percentage of profitable transactions made by Mark Elliott Boulding is 50%.
What is the average return per transaction made by Mark Elliott Boulding?
The average return per transaction made by Mark Elliott Boulding is 3.10%.
What stocks does Mark Elliott Boulding hold?
Mark Elliott Boulding holds: PTCT stocks.
What was Mark Elliott Boulding’s latest transaction?
Mark Elliott Boulding latest transaction was an Informative Sell of $158.87K.
What was Mark Elliott Boulding's most profitable transaction?
Mark Elliott Boulding’s most profitable transaction was an Informative Sell of PTCT stock on February 2, 2023. The return on the trade was 46.80%.
What is Mark Elliott Boulding's role in PTC Therapeutics?
Mark Elliott Boulding's role in PTC Therapeutics is EXEC. VP AND CLO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.